INTRODUCTION {#h0.0}
============

It is estimated that 2 billion people are latently infected with *Mycobacterium tuberculosis*, representing potential cases of reactivation and transmission and hampering better control of the disease ([@B1]). As tuberculosis (TB) infection progresses, the bacilli face adverse environmental conditions to which they respond by entering into a silent phase known as dormancy. In this phase, the bacteria are able to survive for the entire life of the host causing latent infection. Eventually, they can also reactivate and cause active disease when the host's immune system becomes weakened ([@B2]). Bacterial adaptation to the different stages of the infection involves fine regulation of gene expression. Global transcriptome analysis has identified critical regulators of gene expression such as the *phoP* virulence regulator ([@B3]), the *kstR* cholesterol regulator ([@B4]), the *dosR* hypoxia regulator ([@B5]), or Rv0081, which was also recently proposed as a hypoxia regulator ([@B6]). The identification of noncoding RNAs in *M. tuberculosis* also suggests that these molecules could regulate microbial adaptation ([@B7], [@B8]). During latency, *M. tuberculosis* is presumed to reside in lipid-rich foamy macrophages ([@B9]) and accumulate internal lipid droplets full of triacylglycerols (TAGs) that are used subsequently as an energy source for persistence ([@B10]). Nevertheless, the bacilli continue replication ([@B11]) and retain low but detectable metabolic activity ([@B12]). It has also been shown that *M. tuberculosis* uses host lipids, in particular, fatty acids and cholesterol, as energy sources during intracellular growth and persistence ([@B13][@B14][@B15]).

Although several *in vitro* models have been used to mimic the environment of dormant bacilli during latency ([@B16][@B17][@B18]), cultures grown in the presence of lipids, the most abundant molecules surrounding bacilli *in vivo*, have not been extensively analyzed.

To gain insight into the process of *M. tuberculosis* adaptation to a fatty acid environment, we developed an *in vitro* model where bacilli were grown in even-length long-chain fatty acids (LC-FAs) as the sole carbon source. Even-length LC-FAs were selected because they are the main LC-FAs found in human cells ([@B19]) and are a major component of TAGs ([@B20]). Although other *in vivo* lipid energy sources cannot be ignored, it is possible that for long-term infection, bacilli might benefit by selecting even-length LC-FAs, avoiding the toxicity associated with other lipid sources ([@B21]).

We analyzed changes in the global transcriptome of *M. tuberculosis* by using high-throughput methods such as strand-specific RNA sequencing (ss-RNA-seq) ([@B22]).

RESULTS AND DISCUSSION {#h1}
======================

The global transcriptome of *M. tuberculosis* in the LC-FA *in vitro* model. {#h1.1}
----------------------------------------------------------------------------

In order to mimic the nutrient conditions presumed to be encountered by *M. tuberculosis* during *in vivo* infection ([@B23]), we cultured *M. tuberculosis* H37Rv in a medium supplemented with a mixture of even-length LC-FAs as the sole carbon source. Growth in LC-FAs was compared to growth in dextrose as a control. We found that growth in LC-FAs was slower than growth in dextrose but reached similar saturation points (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material).

RNA was analyzed by ss-RNA-seq with material from bacilli grown in dextrose to the exponential (DE) and stationary (DS) phases and in LC-FA to the exponential (FE) and stationary (FS) phases (see [Fig. S1](#figS1){ref-type="supplementary-material"}). The sequence depth obtained showed good coverage of the *M. tuberculosis* genome, as indicated by the plateaus reached in all instances by mapping reads against coding sequences (CDS) (see [Fig. S2A](#figS2){ref-type="supplementary-material"}). A normal distribution of the data was achieved in all cases (see [Fig. S2B](#figS2){ref-type="supplementary-material"}) ([@B24]). The number of sequences retained after processing for quality was 13.1 to 19.3 million reads ([Table 1](#tab1){ref-type="table"}). To facilitate the comparison of gene expression, the data were normalized as reads per kilobase per million reads (RPKM). Only genes showing ≥1 RPKM were considered for analysis. Statistical analysis for significant differential gene expression was performed with Fisher exact test (see [Table S1A and B](#tabS1){ref-type="supplementary-material"} in the supplemental material). That analysis gave results consistent with those obtained with the DEGseq package for biological replicates (see [Table S1C and D](#tabS1){ref-type="supplementary-material"}) (see Materials and Methods).

###### 

Transcriptomic profile of *M. tuberculosis* in different carbon sources^[*a*](#ngtab1.1)^

  Reads                         No. (%) of reads in following growth phase:                                 
  ----------------------------- --------------------------------------------- -------------- -------------- -------------
  All                           13.12                                         19.29          18.314         16.054
  All mapped                    8.17 (62.3)                                   10.78 (55.9)   9.56 (53.4)    8.01 (51.2)
  Mapped without rRNA                                                                                       
      Mapped to CDS             0.52 (71.3)                                   0.51 (57.6)    0.28 (61.6)    0.10 (13.4)
      Mapped to IGRs            0.17 (22.4)                                   0.25 (28.0)    0.149 (32.9)   0.62 (83.0)
      Mapped to antisense CDS   0.05 (6.4)                                    0.13 (14.4)    0.02 (5.4)     0.03 (3.6)

Total numbers (in millions) of reads determined under the different conditions tested (upper part) and numbers (percentages) of reads determined by excluding those corresponding to rRNA (lower part) are shown.

We identified all 45 tRNAs ([@B25]) (see [Table S2A](#tabS2){ref-type="supplementary-material"}), all of the most highly expressed small RNAs ([@B7]), and most of the previously identified noncoding RNAs ([@B8]) (see [Table S2B](#tabS2){ref-type="supplementary-material"}). During growth in LC-FAs, gene expression (reads mapped to CDS) was greatly reduced compared with the control, particularly in the stationary phase ([Table 1](#tab1){ref-type="table"}). This low gene expression contrasts with the high number of reads that mapped to intergenic regions (IGRs), suggesting close control mediated by small RNAs in cultures grown with LC-FAs.

Consistent with the high number of reads mapping to IGRs in the FS culture, the four most highly expressed IGRs corresponded to this sample (see [Table S2B and C](#tabS2){ref-type="supplementary-material"}). Two of them, namely, MTS2823 and MTS0977 (see [Table S2C](#tabS2){ref-type="supplementary-material"}), have also shown increased expression during infection ([@B7]), suggesting that they might be important regulators and highlighting the association of the conditions used in our model with the conditions encountered by the bacilli *in vivo.*

More remarkable was the overexpression of tRNAs in FS (see [Table S2A](#tabS2){ref-type="supplementary-material"}), which contrasts with the few transcripts mapped to CDS in FS and which, presumably, was a reflection of low translation activity ([Table 1](#tab1){ref-type="table"}). Aminoacyl tRNAs are involved in cellular processes other than protein synthesis, such as the modification of bacterial membrane lipids via the multiple-peptide resistance factor (MprF) protein ([@B26]). MprF attaches positively charged amino acids to the polar heads of phosphatidylglycerol, effectively neutralizing the negative charge of the membrane ([@B27]) and thus decreasing membrane permeability and susceptibility to antibacterial peptides and cationic antibiotics ([@B28]). The tRNAs involved in these changes are tRNA-Lys, tRNA-Ala, and less frequently tRNA-Arg ([@B26], [@B29]), the same tRNAs that were expressed more in FS than in DS in our model ([Fig. 1](#fig1){ref-type="fig"}). We hypothesize that, in the presence of FA, bacilli modify their envelope by aminoacyl-tRNAs, conferring adaptation to stress and possibly increasing tolerance to antibiotics, a process associated with the dormant stage of *M. tuberculosis* ([@B17]). Whether this attractive mechanism to modify the cell envelope is, in fact, involved in the adaptation and survival of the bacilli during long-term infection remains to be investigated.

![Differential expression of tRNAs in the fatty acid model. Fold change comparison of tRNAs between the stationary and exponential phases under both culture conditions. Fold changes were calculated by calculating DS/DE (black bars) and FS/FE (light brown bars) RPKM ratios.](mbo0021418270001){#fig1}

Comparative analysis of CDS between growth in dextrose and LC-FA showed that majority of genes had similar expression levels, both at exponential and stationary phases (see [Fig. S3A and B](#figS3){ref-type="supplementary-material"} in the supplemental material), with only 10% of the potential CDS being differentially expressed ([Fig. 2](#fig2){ref-type="fig"}; see [Table S3](#tabS3){ref-type="supplementary-material"}). This analysis identified genes with differential expression in all of the functional categories of TubercuList (<http://www.tuberculist.epfl.ch>), with the exception of genes belonging to the PE/PPE category in the exponential phase ([Fig. 2](#fig2){ref-type="fig"}; see [Table S3](#tabS3){ref-type="supplementary-material"}). On the contrary, the PE/PPE category was overrepresented in the stationary phase ([Fig. 2](#fig2){ref-type="fig"} and [Table S3](#tabS3){ref-type="supplementary-material"}), suggesting that when *M. tuberculosis* grows in a fatty acid environment, these abundant proteins ([@B25]) might play an additional role in antigenic variation and immune evasion ([@B30], [@B31]). Contrary to our expectations, genes belonging to the functional category "lipid metabolism" were not overrepresented in either the exponential or the stationary phase ([Fig. 2](#fig2){ref-type="fig"}; see [Table S3](#tabS3){ref-type="supplementary-material"}), a result that could be attributed to the gene redundancy present within this category ([@B25]). Among the most highly differentially expressed genes in FS, we identified *pckA* (*P* = 4^−14^) and *tgs-1* (*P* = 2^−13^) (see [Table S1F](#tabS1){ref-type="supplementary-material"}), both of which play critical roles in the lipid metabolic pathways of *M. tuberculosis* ([@B10], [@B32]). As happens with *pckA*, the gene *icl-1* was also upregulated within the trichloroacetic acid (TCA) cycle (see [Table S1E and F](#tabS1){ref-type="supplementary-material"}), consistent with the central role of these enzymes in *M. tuberculosis* lipid metabolism ([@B13]). Because of the use of only even-length LC-FAs, we did not expect production of propionyl coenzyme A (CoA) from lipid degradation. In agreement with this, we did not detect increased expression of genes belonging to the methylcitrate and methylmalonate pathways ([@B33]).

![Genes differentially expressed in the fatty acid model. Numbers of genes differentially expressed by functional categories according to TubercuList (<http://www.tuberculist.epfl.ch/>) are shown. Circle sizes correspond to the numbers of genes with significant differential expression in fatty acid medium versus dextrose medium. (A) Exponential phase. (B) Stationary phase.](mbo0021418270002){#fig2}

The functional category of "regulatory proteins" was underrepresented in the stationary phase, highlighting the involvement of four genes upregulated in the same phase (FS) ([Fig. 2](#fig2){ref-type="fig"}; see [Table S3](#tabS3){ref-type="supplementary-material"}). Two of these correspond to the known regulators WhiB3, which is associated with redox balance ([@B34]), and DosR, which is related to redox balance, and a major regulator of hypoxia in *M. tuberculosis* ([@B5]). As a result, a large number of DosR-regulated genes were also expressed more in FS than in DS ([Table 2](#tab2){ref-type="table"}; see [Table S1F](#tabS1){ref-type="supplementary-material"}). We also identified the recently reported regulator Rv0081, which is considered a global hypoxic response regulator ([@B6]) and the presumptive transcriptional regulator *nrdR* (<http://www.tuberculist.epfl.ch>).

###### 

Member genes of the dormancy regulon with significantly increased expression in the fatty acid model

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene tag   Gene\     Functional\                  Function (reference)                              RPKM ratio^[*b*](#ngtab2.2)^   *P* value^[*c*](#ngtab2.3)^               
             name      category^[*a*](#ngtab2.1)^                                                                                                                              
  ---------- --------- ---------------------------- ------------------------------------------------- ------------------------------ ----------------------------- ----------- -----------
  Rv0079               10                           Unknown; probable transduction regulatory\        1.59                           2.10                          1.09 E-12   3.37 E-07
                                                    protein ([@B42])                                                                                                           

  Rv0080               10                                                                             ---^[*d*](#ngtab2.4)^          9.00                          ---         1.19 E-09

  Rv0081               9                            Global regulator in hypoxia                       ---                            1.10                          ---         0.014

  Rv0243     *fadA2*   1                            Lipid degradation                                 ---                            1.60                          ---         9.87 E-05

  Rv0569               10                                                                             ---                            3.07                          ---         0.90 E-14

  Rv0570     *nrdZ*    2                            Ribonucleoside-diphosphate reductase              ---                            2.67                          ---         0.004

  Rv1436     *gap*     7                                                                              1.15                           ---                           0.028       ---

  Rv1652     *argC*    7                            Arginine biosynthesis                             ---                            3.00                          ---         8.33 E-05

  Rv1733c              3                            Unknown; probable conserved transmembrane\        2.77                           1.50                          2.62 E-08   0.012
                                                    protein                                                                                                                    

  Rv1738               10                                                                             ---                            1.15                          ---         0.90 E-14

  Rv1813c              10                                                                             3.53                           ---                           1.09 E-12   ---

  Rv1996               0                            Unknown; universal stress family protein          1.93                           1.19                          1.09 E-12   6.27 E-06

  Rv2005c              0                            Unknown; universal stress family protein          ---                            6.50                          ---         3.15 E-13

  Rv2007c    *fdxA*    7                            Ferredoxin FdxA                                   ---                            2,18                          ---         1.09 E-12

  Rv2030c              10                                                                             ---                            5.25                          ---         3.88 E-10

  Rv2031c    *hspX*    0                            Stress protein induced in hypoxia                 ---                            6.05                          ---         0.90 E-14

  Rv2623     TB31.7    0                            Unknown; universal stress family protein          ---                            3.08                          ---         0.90 E-14

  Rv2625c              3                            Unknown; probable conserved transmembrane\        ---                            3.20                          ---         1.44 E-06
                                                    protein                                                                                                                    

  Rv2626c    *hrp-1*   10                                                                             ---                            4.67                          ---         0.90 E-14

  Rv2627c              10                                                                             ---                            2.43                          ---         2.96 E-06

  Rv2628               10                                                                             ---                            1.40                          ---         1.18 E-05

  Rv2629               10                                                                             ---                            1.13                          ---         4.16 E-08

  Rv3127               10                                                                             ---                            1.33                          ---         0.003

  Rv3130c    *tgs-1*   1                            TAG                                               ---                            2.31                          ---         2.07 E-13

  Rv3131               10                           Unknown; putative NAD(P)H nitroreductase          2.89                           4.00                          1.09 E-12   9.04 E-13

  Rv3133c    *devR*    9                            Regulator part of the Dos TCS^[*e*](#ngtab2.5)^   ---                            2.60                          ---         6.54 E-05

  Rv3134c              0                            Unknown; universal stress protein family          1.03                           3.43                          5.99 E-06   3.19 E-10
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Functional categories based on <http://www.tuberculist.epfl.ch>: 0, virulence, detoxification, and adaptation; 1, lipid metabolism; 2, information pathways; 3, cell wall and cell processes; 7, intermediary metabolism and respiration; 9, regulatory proteins; 10, conserved hypothetical proteins.

RPKM ratio according to phase of growth: exponential (FE/DE) or stationary (FS/DS). See [Table S1A and B](#tabS1){ref-type="supplementary-material"} in the supplemental material for the complete set of data. The gene is overexpressed in FE or FS if the ratio is above 1.

Determined by Fisher exact test, in which statistically significant differential expression between two conditions was determined by looking at genes with FDRs of \<0.05 (see Materials and Methods for details).

---, gene with a ratio of \<1 or with no significantly increased expression under those conditions.

TCS, two-component regulatory system.

Given that WhiB3 and DosR, two heme sensor proteins related to intracellular redox balance ([@B34], [@B35]), were identified as key components of the adaptation of *M. tuberculosis* to growth in LC-FA, we searched for significantly overexpressed genes involved in redox balance. Independently of the phase of growth, bacilli cultured in LC-FAs had a higher percentage of significantly overexpressed genes associated with reductive stress (see [Table S4A](#tabS4){ref-type="supplementary-material"}). These results suggest that growing *M. tuberculosis* in a fatty acid medium putatively causes a burst in reductive stress and thus the required molecules to maintain redox balance would be induced in order to allow cell growth under these conditions. An imbalance of the redox equilibrium leads to either reductive or oxidative stress responses, the latter well documented to be involved in *M. tuberculosis* infection ([@B36]). However, the contribution of its counterpart, namely, reductive stress, has barely been considered thus far and occurs when reducing equivalents, such as NADH, FADH, or NADPH, are abnormally increased ([@B34], [@B37]). In our LC-FA cultures, the reducing equivalents that could be generated by both β-oxidation of LC-FAs and TCA metabolic activities would result in reductive stress that must be cleared for survival via reductive sinks, such as polymer deposition, reverse TCA, or nitrate reductase activity, among others ([@B35], [@B37]). The induced expression of 11 genes with allegedly reductive sink activity, 8 of which are involved in polymer deposition, might indicate the participation of reductive stress during growth of *M. tuberculosis* in LC-FA ([Table 3](#tab3){ref-type="table"}). Our results suggest that polymer deposition, which includes TAG accumulation, as well as the formation of other complex lipids, such as SL-1, PAT, DAT, and PDIM ([Table 3](#tab3){ref-type="table"}), was the main reductive sink mechanism used by *M. tuberculosis* when grown on fatty acids as carbon sources. This is consistent with the observed lipid droplets inside *M. tuberculosis* during the stationary phase of growth in LC-FA medium ([Fig. 3A](#fig3){ref-type="fig"}) and agrees with the suggestion that lipid accumulation could be a reputed marker of *M. tuberculosis* during latent infection ([@B17], [@B38]). The accumulation of lipid droplets inside *M. tuberculosis* in our LC-FA *in vitro* model, together with the high expression of *tgs-1*, prompted us to test for drug tolerance, another dormancy-related characteristic of the bacilli. To do this, we determined the drug susceptibility of *M. tuberculosis* to a mixture of four drugs known to be active against replicating and nonreplicating bacilli ([@B39]). Our results showed that *M. tuberculosis* manifested greater drug tolerance in the presence of lipids than during growth in dextrose ([Fig. 3B and 3C](#fig3){ref-type="fig"}). The relationship between the detected overexpression of tRNAs and drug tolerance deserves further investigation, as it represents an attractive idea regarding the participation of tRNAs in the dormant stage of *M. tuberculosis*.

###### 

Genes with significantly increased expression and their putative relation to reductive stress

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene tag                    Gene\     Growth\   Functional\                  Function                                Putative influence\                     RPKM\                     *P* value^[*e*](#ngtab3.4)^
                              name      phase     category^[*b*](#ngtab3.1)^                                           on reductive stress^[*c*](#ngtab3.2)^   ratio^[*d*](#ngtab3.3)^   
  --------------------------- --------- --------- ---------------------------- --------------------------------------- --------------------------------------- ------------------------- -----------------------------
  Rv0243^[*a*](#ngtab3.5)^    *fadA2*   FS        1                            Lipid degradation                                                               1.60                      9.87 E-05

  Rv0570^[*a*](#ngtab3.5)^    *nrdZ*    FS        2                            Ribonucleoside-diphosphate reductase    NADH/NADPH![](downarrow.jpg)            2.67                      0.004

  Rv0694                      *lldD1*   FE        7                            [l]{.smallcaps}-Lactate dehydrogenase                                           1.09                      0.029

  Rv0697                                FE        7                            Unknown; probable dehydrogenase                                                 4.33                      0.001

  Rv1180                      *pks-3*   FE        1                            Probable polyketide synthase            Polymer deposition![](downarrow.jpg)    3.20                      5.9 E-04

  Rv1436^[*a*](#ngtab3.5)^    *gap*     FE        7                            Probable GADPH^[*f*](#ngtab3.6)^        NADH![](uparrow.jpg)                    1.15                      0.028

  Rv1652^[*a*](#ngtab3.5)^    *argC*    FS        7                            Arginine biosynthesis                   NADH/NADPH![](uparrow.jpg)              3.00                      8.33 E-05

  Rv1908c                     *katG*    FE        0                            Catalase/peroxidase                                                             1.57                      0.004

  Rv2382c                     *mbtC*    FE        1                            Polyketide synthase                     Polymer deposition![](downarrow.jpg)    4.00                      0.032

  Rv2590                      *fadD9*   FE        1                            Lipid degradation                       NADH/NADPH![](uparrow.jpg)              3.71                      5.68 E-07

  Rv2781                                FE        7                            Oxidoreductase                                                                  3.80                      1.94 E-10

  Rv2794c                     *pptT*    FE        1                            4′-Phosphopantetheinyl transferase      Polymer deposition![](downarrow.jpg)    1.18                      0.041

                                        FS                                                                                                                     3.00                      8.33 E-05

  Rv2931                      *ppsA*    FS        1                            PDIM biosynthesis                       Polymer deposition![](downarrow.jpg)    2.00                      0.041

  Rv2995c                     *leuB*    FS        7                            Leucine synthesis                       NADH/NADPH![](uparrow.jpg)              2.60                      6.54 E-05

  Rv2996c                     *serA1*   FS        7                            [l]{.smallcaps}-Serine synthesis        NADH/NADPH![](uparrow.jpg)              3.00                      0.019

  Rv3130c^[*a*](#ngtab3.5)^   *tgs-1*   FS        1                            TAG synthase                            Polymer deposition![](downarrow.jpg)    2.31                      2.07 E-13

  Rv3131^[*a*](#ngtab3.5)^              FE        10                           Unknown                                 Reductant collector![](downarrow.jpg)   2.89                      1.09 E-12

                                        FS                                     Putative NAD(P)H nitroreductase                                                 4.00                      9.04 E-13

  Rv3145                      *nuoA*    FE        7                            Probable NADH-dehydrogenase             Reductant collector![](downarrow.jpg)   1.03                      0.008

  Rv3229c                     *desA3*   FE        1                            Lipid desaturase                        Polymer deposition![](downarrow.jpg)    3.80                      1.09 E-12

  Rv3230                                FE        7                            Oxidoreductase                                                                  1.32                      0.006

  Rv3371                                FS        1                            TAG synthesis                           Polymer deposition![](downarrow.jpg)    2.00                      0.041

  Rv3825c                     *pks-2*   FE        1                            Probable polyketide synthase            Polymer deposition![](downarrow.jpg)    1.27                      1.34 E-04
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Member of the DosR regulon.

Functional categories based on <http://www.tuberculist.epfl.ch>: 0, virulence, detoxification, and adaptation; 1, lipid metabolism; 2, information pathways; 7, intermediary metabolism and respiration; 10, conserved hypothetical proteins.

RPKM ratio according to phase of growth: exponential (FE/DE) or stationary (FS/DS). The gene is overexpressed in FE or FS if the ratio is \>1. See [Table S1A and B](#tabS1){ref-type="supplementary-material"} in the supplemental material for the complete set of data.

Arrows indicate the putative contributions of genes to the increase (up arrow) or decrease (down arrow) in reductive equivalents. Absence of an arrow indicates a gene that could contribute to both an increase and a decrease in reductive equivalents, for example, an oxidoreductase-encoding gene.

Determined by Fisher exact test, in which statistically significant differential expression between two conditions was determined by looking at genes with FDRs of \<0.05 (see Materials and Methods for details).

GAPDH, glyceraldehyde 3-phosphate dehydrogenase.

![Dormancy-related phenotype of *M. tuberculosis* grown in the fatty-acid model. (A) Electron micrographs of *M. tuberculosis* grown under different carbon sources. White arrows indicate presumed lipid bodies identified in LC-FA at stationary phase. Magnification: ×60,000 (DE, DS, and FE) or ×12,000 (FS). Exponential- and stationary-phase cultures were incubated with drugs in the presence of dextrose or fatty acids. Cultures were collected after 7, 14, or 21 days of exposure to drugs as estimated by CFU counting (B) or by calculating the MPN/ml (C) (see Materials and Methods for details). The R, MX, MZ, and AK concentrations used were 8, 4, 8, and 8 µg/ml, respectively. Means and standard deviations of four experiments are shown.](mbo0021418270003){#fig3}

Comparison of the LC-FA model with other dormancy-related *in vitro* models. {#h1.2}
----------------------------------------------------------------------------

The host environmental cues that trigger the *M. tuberculosis* dormant stage or long-term infection are not fully elucidated, although changes associated with hypoxia, starvation, and low pH have been shown to be important ([@B17]). To test the suitability of growth in LC-FA as an *in vitro* model, we compared the gene expression profile of our lipid-enriched condition with other well-established *in vitro* models designed to mimic the hypoxic and starvation conditions faced by the pathogen within the host. Genes with significantly higher expression during growth in LC-FAs (see [Table S1E and F](#tabS1){ref-type="supplementary-material"} in the supplemental material) were compared with the highest-scoring genes derived from array data obtained from the meta-analysis published by Murphy and Brown ([@B40]). The total number of genes shared by any two conditions was very similar, with no significant differences in percentages (see [Fig. S4A](#figS4){ref-type="supplementary-material"}). Therefore, growth in LC-FA can be another suitable *in vitro* model for the analysis of genes related to the dormant stage of *M. tuberculosis*. It is noteworthy that growth in LC-FAs and growth under hypoxia conditions shared more genes belonging to the DosR regulon than either condition compared to growth during starvation (see [Fig. S4A](#figS4){ref-type="supplementary-material"}). Interestingly, one of the LC-FAs used was palmitate, a fatty acid present in the culture medium used in one of the classical *in vitro* models of persistence ([@B41]).

Because of the suggested involvement of reductive stress in the growth of *M. tuberculosis* in a lipid-enriched medium, we sought to identify genes related to reductive stress in the same hypoxia and starvation data set used for the above analysis ([@B40]). Of the 371 genes associated with reductive stress in the *M. tuberculosis* genome (<http://www.tuberculist.epfl.ch>), we excluded genes belonging to the functional category of "lipid metabolism" to avoid bias toward the fatty acid model. We compared the remaining 216 genes with the 206 highest-scoring genes for all three data sets (see [Fig. S4B](#figS4){ref-type="supplementary-material"}). The number of genes related to reductive stress identified in each case was different, with the highest represented by LC-FA (24/206 genes, 11.1%), followed by hypoxia (14/206 genes, 6.5%), and the lowest represented by starvation (7/206 genes, 3.2%). The differences among percentages were close to significant between hypoxia and LC-FA and clearly significant between starvation and LC-FA (see [Fig. S4B](#figS4){ref-type="supplementary-material"}). Recently, it has been shown that reductive stress could play a role during long-term mycobacterial infection and that lipids could be stakeholders in this process ([@B37]). Our results also indicate that growth in LC-FAs might be a more suitable *in vitro* model to better test the putative involvement of reductive stress during the long-term infection of *M. tuberculosis*.

Genes involved in the adaptation of *M. tuberculosis* to a lipid environment. {#h1.3}
-----------------------------------------------------------------------------

The global analysis of the *M. tuberculosis* transcriptome showed increased expression of genes involved in various metabolic processes and identified specific genes that provide insight into cellular adaptation during growth with fatty acids as the sole carbon sources ([Fig. 2](#fig2){ref-type="fig"}; see [Table S1E and F](#tabS1){ref-type="supplementary-material"}). Searching for a set of genes related to the pathways used by *M. tuberculosis* to adapt to a lipid environment, we identified 14 genes that had significantly increased expression in FE and FS than in DE and DS, respectively ([Table 4](#tab4){ref-type="table"}) ([@B42], [@B43]). These genes therefore characterized the adaptation of the bacilli to growth in LC-FA medium and thus provide a lipid signature for *M. tuberculosis*; this overexpression was confirmed by quantitative reverse transcription (qRT)-PCR (see [Fig. S5](#figS5){ref-type="supplementary-material"}).

###### 

Lipid signature of *M. tuberculosis* grown in the fatty acid model

  Gene tag                    Gene name   Functional category^[*b*](#ngtab4.1)^   Function (reference)                                                                  RPKM ratio^[*c*](#ngtab4.2)^   *P* value^[*d*](#ngtab4.3)^                
  --------------------------- ----------- --------------------------------------- ------------------------------------------------------------------------------------- ------------------------------ ----------------------------- ------------ -----------
  Rv0079^[*a*](#ngtab4.4)^                10                                      Unknown; probable transduction regulatory protein ([@B42])                            1.59                           2.10                          01.09 E-12   3.37 E-07
  Rv0211                      *pckA*      7                                       Phosphoenolpyruvate carboxykinase                                                     1.03                           1.83                          0.021        4.03 E-14
  Rv0467                      *icl-1*     7                                       Isocitrate lyase                                                                      3.88                           1.52                          1.58 E-08    3.89 E-09
  Rv1066                                  10                                      Unknown; rhodanase like domain^[*e*](#ngtab4.5)^                                      2.11                           4.10                          1.28 E-07    9.04 E-13
  Rv1184c                                 3                                       Unknown; possible exported protein, probable lipase, esterase or quitinase ([@B43])   4.80                           5.00                          3.69 E-07    0.024
  Rv1733c^[*a*](#ngtab4.4)^               3                                       Unknown; probable conserved transmembrane protein                                     2.77                           1.50                          2.62 E-08    0.012
  Rv1996^[*a*](#ngtab4.4)^                0                                       Unknown; universal stress protein family                                              1.93                           1.19                          1.09 E-12    6.27 E-06
  Rv2794c                     *pptT*      1                                       4′-Phosphopantetheinyl transferase                                                    1.18                           3.00                          0.041        8.33 E-05
  Rv3131^[*a*](#ngtab4.4)^                10                                      Unknown; putative NAD(P)H nitroreductase                                              2.89                           4.00                          1.09 E-12    9.04 E-13
  Rv3134c^[*a*](#ngtab4.4)^               10                                      Unknown; universal stress protein family                                              1.03                           3.43                          5.99 E-06    3.19 E-10
  Rv3416                      *whiB3*     9                                       Redox sensor; transcriptional regulatory protein                                      2.50                           1.09                          0.003        0.009
  Rv3612c                                 10                                      Unknown                                                                               2.00                           1.10                          0.029        0.014
  Rv3614c                     *espD*      3                                       Unknown; ESX-1 secretion associated protein                                           2.81                           1.50                          1.09 E-12    9.04 E-13
  Rv3686c                                 10                                      Unknown                                                                               1.82                           3.00                          1.60 E-08    3.26 E-07

Member of the DosR regulon.

Functional categories based on <http://www.tuberculist.epfl.ch>: 0, virulence, detoxification, and adaptation; 1, lipid metabolism; 3, cell wall and cell processes; 7, intermediary metabolism and respiration; 9, regulatory proteins; 10, conserved hypothetical proteins.

RPKM ratio according to phase of growth: exponential (FE/DE) or stationary (FS/DS). The gene is overexpressed in FE or FS if the ratio is \>1. See [Table S1A and B](#tabS1){ref-type="supplementary-material"} in the supplemental material for the complete set of data.

Determined by Fisher exact test, in which statistically significant differential expression between two conditions was determined by looking at genes with FDRs of \<0.05 (see Materials and Methods for details).

<http://genome.tbdb.org>, accessed December 2012.

Several of these lipid signature genes are involved in cellular intermediary metabolism. This includes the genes *pckA* and *icl*, indicating that bacteria are actively using the glyoxylate shunt, consistent with the central role of these enzymes in *M. tuberculosis* lipid metabolism ([@B13], [@B32]). The gene *pckA* is required for growth in fatty acids, and mutants defective in *pckA* are attenuated in both macrophage and mouse infections ([@B32]). Moreover, *icl* and *pckA* are also upregulated in nongrowing bacilli in murine models ([@B13], [@B15]).

Two lipid signature genes belong to the functional category of "lipid metabolism" (<http://www.tuberculist.epfl.ch>): Rv1184, which codes for an exported protein that is able to perform lipid degradation and *pptT*, which encodes a phosphopantetheinyl transferase that activates the polyketide synthases ([@B44]). Two additional genes are related to membrane activity allegedly involved in either the transport of metabolites (Rv1733) or associated with the ESX-1 secretion system of *M. tuberculosis* (Rv3614c), the latter coding for EspD.

WhiB3 was the single transcriptional regulator detected as part of the signature. This heme-based sensor, which is associated with intracellular redox balance, links environmental signaling with cellular metabolism ([@B34]). Interestingly, five of the members of the lipid signature belong to the DosR hypoxia regulon. This suggests that induction of the DosR transcriptional regulator could result from cotranscription from the upstream Rv3134c gene ([@B45], [@B46]), which is part of the lipid signature. The Rv3134c gene harbors a *usp* domain, as does another gene of the lipid signature, Rv1996. One of the DosR-regulated genes, Rv0079c, has recently been reported as a dormancy-associated translation inhibitor (DATIN) that inhibits *in vitro* protein synthesis. Overexpression of a recombinant DATIN in *Escherichia coli* and in *Mycobacterium bovis* BCG decreased the growth rate of these microorganisms ([@B42]). We therefore suggest that the overexpression of this gene in both the exponential and stationary phases could be the responsible for the observed slower growth of *M. tuberculosis* in LC-FA (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material). Many of the genes included in the lipid signature are of unknown function, showing our scarce knowledge of how *M. tuberculosis* adapts to a lipid-enriched condition. One of these genes, Rv1733c, codes for a hypothetical protein reported to be induced by hypoxia and starvation ([@B5]).

To investigate whether these genes could be coregulated at the transcriptional level, we searched for a possible consensus motif 500 nucleotides (nt) upstream of each open reading frame (ORF) ([@B47]). We identified a DNA motif in 12 of the 14 genes analyzed ([Fig. 4](#fig4){ref-type="fig"}). The probability that this motif could be present in these genes by chance was 1E-07, thus suggesting a biological function of the motif in genes of the lipid signature. Interestingly, the motif was not found upstream of *whiB3*, opening the possibility that this gene product could be involved in transcriptional regulation of the lipid signature genes. The identification of an antisense transcript of the *whiB3* gene in DS ([Fig. 4B.2](#fig4 fig2){ref-type="fig"}) strongly suggests the involvement of noncoding RNA in *whiB3* gene regulation under lipid-enriched conditions.

![Features of lipid signature genes. (A) Sequence logo of the lipid signature motif. The nucleotide sequence was determined by performing Gibbs sampling of the 500 bp upstream of the initiation codon of the lipid signature genes (see Materials and Methods for details). In the representation of the consensus sequence shown in the graph, the height of each nucleotide indicates the level of conservation. (B) Differential transcription of the *whiB3* gene. Artemis view of the reads mapped to the *whiB3* gene under the conditions tested. The blue arrow indicates the orientation of *whiB3* transcription. (B.1) Exponential phase: red, dextrose; purple, LC-FA. (B.2) Stationary phase: green, dextrose; blue, LC-FA. Antisense transcription is identified in the stationary phase of growth in dextrose.](mbo0021418270004){#fig4}

To assess the relevance of these genes for *M. tuberculosis* growth, we next compared this list with previously reported studies aimed at identifying essential genes. Interestingly, none of the 14 lipid signature genes were found to contain IS*6110* insertions in the *in vivo* survey of 533 isolates worldwide, with the exception of Rv1733, which had an IS*6110* insertion in 2 of the 533 isolates analyzed ([@B48]). In contrast, 10 of the 14 genes are considered nonessential for *in vitro M. tuberculosis* growth, based on transposon mutagenesis ([@B49]). These data support our proposal that the LC-FA model could be more closely related to the conditions that the bacilli confront *in vivo* during TB infection.

Final remarks. {#h1.4}
--------------

On the basis of the results presented here, we propose the following scenario for *M. tuberculosis* growing on even-length LC-FAs ([Fig. 5](#fig5){ref-type="fig"}). Lipids surrounding the bacilli, TAG or LC-FAs, are hydrolyzed by lipases (such as Rv1184) and then internalized through receptors (Rv1733c). The lipids are subsequently converted to acetyl-CoA by β-oxidation and consumed by the glyoxylate cycle (Icl1). At this point, PckA can regenerate phosphoenolpyruvate to continue the cycle. As a consequence, both CO~2~ and the reducing equivalents NADH and NADPH increase and are sensed by the DosR, Rv0081, and WhiB3 transcriptional regulators. These and probably other stress conditions induce the expression of genes such as *pptT*, *pks-2*, *pks-3*, and *tgs-1*, which are responsible for the synthesis of complex lipids that balance the redox state of the cell by polymer deposition. The detection of *espD* suggests secretion, possibly of toxic compounds. On the other hand, several genes of the DosR regulon are induced: stress proteins (Rv1996, and Rv3134c, which are cotranscribed with *dosR*) and other reductive sinks (Rv3131), inhibitors of protein synthesis (Rv0079), and heme stabilization proteins (*fdxA*). Proteins required for porphyrin synthesis (HemA and HemC) are also induced (see [Table S4B](#tabS4){ref-type="supplementary-material"}). Finally, the high expression of tRNAs could modify membrane properties, resulting in tolerance to environmental stresses and antibiotics. We propose that when *M. tuberculosis* grows on LC-FAs as sole carbon sources, the cells change their gene expression profile by inducing genes required for stress protection, as well as genes required for its survival during long-term infection. Our results therefore provide insight into the physiological responses of tubercle bacilli when grown in a lipid-rich environment, a poorly studied aspect of TB infection.

![Proposed scenario of *M. tuberculosis* growth in the fatty acid model. Growth of *M. tuberculosis* during the *in vitro* model of even-LC-FA is shown. See the text (final remarks) for details.](mbo0021418270005){#fig5}

Studying the metabolic activity of *M. tuberculosis* during latent infection is not an easy task ([@B50]). TB was recently described as a continuum, from active disease to latent infection, and the accumulation of data indicates that latency might not be considered a single condition either ([@B50]). Although it is still unclear, it appears that dormant bacilli include cells with different metabolic activities, from slowly growing to nondividing stages that vary in terms of redox balance and require responses to oxidative stress or reductive stress, balanced by the cooperation of main regulators, such as WhiB3, DosR, and the recently identified Rv0081 ([@B6]). The development of new drugs against dormant bacilli has been difficult probably because of our poor knowledge of real metabolic activity of *M. tuberculosis* during the complex period of latency. The data derived from the use of the LC-FA *in vitro* model represent a novel tool suitable for the study of the susceptibility of *M. tuberculosis* to drugs during latency from a new perspective.

In summary, our results show a new scenario for the adaptation of *M. tuberculosis* to a lipid-rich environment, presenting evidence of the role of reductive stress and giving insights into the participation of novel molecules such as noncoding RNAs and tRNAs. These could play important roles in the adaptation of the bacteria for long-term survival. During the coevolution of the human host and the tubercle bacilli, these adaptations have probably been crucial for bacterial survival and the establishment of a balanced coexistence, represented by a successful infection without disease, which we know as latent TB.

MATERIALS AND METHODS {#h2}
=====================

Bacterial strain and culture conditions. {#h2.1}
----------------------------------------

*M. tuberculosis* H37Rv (donated by The Pasteur Institute, Paris, France) was grown at 37°C in 100 ml of Dubos broth (Difco) supplemented with 10% ADC (Middlebrook) in a 1-liter flask to an optical density at 600 nm (OD~600~) of 0.5. The culture was divided in two, and cells were pelleted by centrifugation and resuspended in (i) Dubos broth base (without glycerol) (BD Difco) containing 0.5% albumin (Sigma Fraction V, fatty acid free) and supplemented with a mixture of 0.003% FA with even an number of carbon atoms (0.001% each oleic \[18 carbon atoms\], palmitic \[16 carbon atoms\], and stearic \[18 carbon atoms\] acids) or (ii) Dubos medium with 0.5% albumin--0.75% dextrose--0.04% catalase (ADC enrichment). Cultures were grown with agitation at 200 rpm at 37°C, and growth was monitored by measuring the OD~600~.

RNA isolation. {#h2.2}
--------------

Total RNA was isolated from cultures in the exponential and stationary phases as previously described ([@B51]). Basically, cultures were harvested by centrifugation and pellets were resuspended in guanidinium chloride buffer (6 M guanidinium chloride, 0.1% Tween 80, 1 mM 2-mercaptoethanol, 10 mM EDTA) in a proportion of 1 ml of buffer/100 ml of culture. Cells were lysed mechanically in a FastPrep (Thermo Scientific) with 150- to 200-µm glass beads (Sigma-Aldrich) by performing four lysis cycles of 15 s each at high speed (6.5 m/s). Nucleic acids were purified with phenol-chloroform-isoamyl alcohol (25:24:1), and RNA was differentially precipitated with 0.4 volume of absolute ethanol (added drop by drop). Finally, RNA was washed three times with Trizol reagent (Invitrogen). RNA integrity was analyzed with a bioanalyzer (Agilent Technologies) and quantified by spectrophotometry with the NanoDrop ND-1000 (Thermo Scientific).

Library preparation and sequencing. {#h2.3}
-----------------------------------

Strand-specific RNA-seq libraries were prepared in accordance with the protocol described by Waldbauer and coworkers ([@B52]). Briefly, The DNase-treated RNA (100 ng) was fragmented by divalent-cation hydrolysis (Fragmentation Buffer; Ambion, Austin, TX) at 70°C for 12 min to yield fragment sizes between 50 and 300 nt. After precipitation with ethanol, fragments were subjected to poly(A) tailing and end repairing (NEB Reagents). RNA was treated with Antarctic phosphatase (New England Biolabs) and then phosphorylated at the 5′ RNA end with T4 polynucleotide kinase. The transcribing strand was labeled by ligation of a 5′ hybrid DNA-RNA primer and after purification with RNA clean XP beads (Beckman Coulter Genomics), the first-strand cDNA synthesis reaction was carried out with SuperScript II reverse transcriptase (Invitrogen) and Illumina's poly(T) primer and deoxynucleoside triphosphates (20 mM). Reaction components were removed with Agencourt AMPure XP SPRI beads (Beckman), and primary transcripts were enriched with *Pfu* Hi Fidelity polymerase (Invitrogen) and the Illumina spacers as primers. Illumina adaptors and bar codes were ligated by PCR in accordance with the manufacturer's instructions. Libraries were purified with SPRI beads (Beckman) and quantified with a NanoDrop (Bio-Rad). Sequencing was performed with the Illumina technology at Ambry Genetics.

RNA-seq data analysis. {#h2.4}
----------------------

Sequence reads were processed to remove poly(A) and spacer sequences, and only those with quality scores of \>30 (Illumina 1.3+) and a minimal length of 50 bases were used for analysis. Assessment of read quality was done with the FASTX toolkit v. 0.0.13 (<http://hannonlab.cshl.edu/fastx_toolkit/index.html>). The reads were mapped against the *M. tuberculosis* H37Rv reference genome (accession no. NC000962.2) with Bow tie v. 0.12.7 ([@B53]) and visualized with the Artemis sequence visualization and annotation tool ([@B54]). Reads that mapped to more than one site where excluded. For the analysis, only those reads for which 50% of the sequence length fell within the annotated ORF were considered part of the ORF. For the identification of novel expressed IGRs in the transcriptome, clean reads were analyzed with an in-house algorithm that identifies genomic regions with a minimum depth of 10 reads and a minimum length of 50 nt. These zones were then annotated by comparison with the reference genome, with annotation coming from literature and the TubercuList database (<http://www.tuberculist.epfl.ch>). For example, transcripts are annotated as novel intergenic if they show expression according to the criteria mentioned and they do not overlap any previously annotated feature in the genome.

Measurement of drug activity. {#h2.5}
-----------------------------

The activity of a drug mixture containing rifampin (R), moxifloxacin (MX), metronidazole (MZ) and amikacin (AK) against exponential- and stationary-phase cultures of *M. tuberculosis* grown in dextrose or FA medium was tested. R, MZ, and AK were purchased from Sigma Chemicals (United States); MX was obtained from Bayer (Mexico). R was dissolved in ethanol; MZ, AK, and MX were dissolved in distilled water. To determine drug activity, 4- to 6-day-old (exponential-phase) cultures and 15-day-old (stationary-phase) cultures (containing at least 1 × 10^6^ CFU/ml) were incubated with the drug combination for 0, 7, 14, or 21 days; R, MX, MZ, and AK were used at their maximum drug concentration in serum at 8, 4, 8, and 8 µg/ml, respectively ([@B39]). After incubation, culture CFU counts per milliliter were determined by plating appropriate dilutions as described previously ([@B55]). In parallel, 1 ml of each culture was taken to perform 10^−1^ to 10^−3^ dilutions with Dubos broth. One milliliter of every dilution was transferred to each of three tubes containing 9 ml of Dubos broth with or without the fatty acid mixture, accordingly. These broth cultures were examined for visible turbidity every 7 days over a 3-week period of incubation at 37°C. The most probable number (MPN) of viable bacilli was then estimated while taking in account the patterns of positive and negative tubes (<http://www.fda.gov/food/foodscienceresearch/laboratorymethods/ucm109656.htm>; accessed January 2013). Plating of different culture samples on blood agar medium showed the absence of bacteria other than mycobacteria. Growth of *M. tuberculosis* in turbid tubes was confirmed by Ziehl-Neelsen staining and colonial morphology on Middlebrook 7H11

Analysis of the upstream regions of the genes belonged to the lipid signature. {#h2.6}
------------------------------------------------------------------------------

For each gene, 500 nt were taken upstream of the initiation codon. These regions were fed into the Gibbs sampling algorithm, and the sequences were analyzed to detect any possible bias in their composition. This was done by means of the program "unifiedcpp." Once corrected for possible bias, the samples were run with the following parameters: k-mer, 12 to 24 nt; -n, for nucleic acid alphabet; -E 3, maximum number of sites to find; -S 20, number of seeds to try; -i 1,000, number of iterations. The probability of the motif arising by chance was determined by means of the hypergeometric distribution ([@B56]). For this, the number of genes in which the motif was present in the 500-nt upstream region in H37Rv was calculated. It turned out that 767 of the 4,060 genes had the motif (this is the population distribution), so we wanted to calculate the probability of drawing 12 out of 14 genes given the population distribution (767/4,060).

qRT-PCR of selected genes. {#h2.7}
--------------------------

The total transcripts of selected genes were measured by real-time qRT-PCR. Quantification was performed with gene-specific primers (see [Table S5](#tabS5){ref-type="supplementary-material"}) and SYBR green (Molecular Probes, Inc.). Samples were subjected to 40 cycles of amplification (denaturation at 95°C for 30 s, specific annealing temperature for 15 s, and extension at 72°C for 15 s) with a final extension at 72°C for 5 min. To ensure that the fluorescence levels detected were due to the amplification of a specific product, a melting curve analysis was performed. Absolute analysis was carried out. To do this, a standard curve was obtained for each set of primers by using 10-fold dilutions of known amounts of *M. tuberculosis* H37RV chromosomal DNA (1,000, 10,000, 100,000, and 1,000,000 theoretical copies). Threshold cycle values of each RNA quantitation were interpolated to standard curve to obtain gene expression (number of gene copies per microliter). Normalization of these data was performed by using 16S rRNA expression levels.

Transmission electron microscopy. {#h2.8}
---------------------------------

Cells were harvested by centrifugation at 16,000 × *g*, washed in sterile phosphate-buffered saline (PBS), and fixed in 2.5% (vol/vol) glutaraldehyde--0.1 M sodium phosphate for 1 h. Cells were recovered and resuspended in 1% (wt/vol) osmium tetroxide for 1 h. Cells were then dehydrated through treatment with a series of ethanol solutions (30, 40, 50, 60, 70, 80, and 90%); each treatment was performed twice for 10 min each time. A final dehydration step was done twice with 100% ethanol for 15 min. Samples were embedded in EPON 812 resin (EMS). This resin was polymerized at 60°C for 24 h. Resin blocks were cut in a Leica Ultracut UCT Ultratome to a 70-nm thickness, placed on 200-mesh copper grids (EMS), and stained with 30% (wt/vol) uranyl acetate--70% (vol/vol) methanol and counterstained with Reynolds lead citrate buffer. Samples were examined with a JEOL JEM-1010 transmission electron microscope with an acceleration voltage of 60 kV.

Statistical analysis. {#h2.9}
---------------------

Statistical analysis for differential gene expression was evaluated by using RPKMs as expression values and Fisher's exact test on a two-by-two contingency table ([@B57]) on a per-gene basis in which the two columns of the table were separated by reads that overlap the gene's ORF and reads that do not overlap the ORF, and the two rows were separated by the two compared samples (FE versus DE or FS versus DS). Significant differences were determined with Fisher's exact test with the additional criteria of a false-discovery rate (FDR) of \<5%. The results were consistent with those obtained with the DEGseq package for biological replicates ([@B58]).

Nucleotide sequence accession number. {#h2.10}
-------------------------------------

The RNA-seq data sets have been deposited in the NCBI Gene Expression Omnibus ([@B59]) under accession number GSE47863.

SUPPLEMENTAL MATERIAL {#h3}
=====================

###### 

Growth of *M. tuberculosis* in LC-FAs. Growth curves of *M. tuberculosis* cultured in the presence of dextrose (Dubos ADC media 1 \[circles\] and 2 \[triangles\]) or LC-FA (Dubos LC-FA media 1 \[large squares\] and 2 \[small squares\]). The results of two independent experiments (1 and 2, respectively) are shown. The arrows indicate that the exponential-phase RNA samples were taken when cultures reached OD~600~ of \~0.3 and 0.4 (which correspond to day 7 in Dubos ADC medium and day 8 in LC-FAs) and that stationary-phase RNA samples were taken when cultures reached an OD~600~ of \~0.6 (which corresponds to day 15). Download

###### 

Figure S1, JPG file, 0.2 MB

###### 

RNA-seq library data. (A) Saturation curves showing a cumulative plot of reads from each individual condition versus the number of genes covered at different sequencing depths. Saturation was reached under all of the conditions since an increase in the number of reads did not result in the detection of additional genes. (B) Data were transformed by the method proposed by Huber et al. ([@B24]) by means of the vsn R Bioconductor package (R Development Core Team, 2008), which is available at <http://www.bioconductor.org>. Transformation and calibration of data were carried out as follows: h*x* = arsinh*xs* h*x* = arsinh*x*/*s*, where *x* is the number of RPKMs and *s* is the standard deviation of these RPKMs in the replicates of each experiment. Download

###### 

Figure S2, JPG file, 0.5 MB

###### 

Genes differentially expressed in the LC-FA model of *M. tuberculosis*. Volcano plots showing each functional category that is represented as indicated in the panel. Significant differences were determined with Fisher's exact test. See [Tables S2](#tabS2){ref-type="supplementary-material"} and [S3](#tabS3){ref-type="supplementary-material"} in the supplemental material for the complete set of data. (A) Exponential phase of growth. (B) Stationary phase of growth. Download

###### 

Figure S3, JPG file, 1.4 MB

###### 

Comparison of LC-FA, hypoxia, and starvation *in vitro* models. Shown is a Venn diagram comparison of genes overexpressed in the three *in vitro* models: hypoxia, starvation ([@B40]), and LC-FA (this work). (Top) the 206 highest-scoring genes identified in the *in vitro* models were compared to each other (A) or for the presence of genes related to reductive stress according to TubercuList (<http://tuberculist.epfl.ch/>), excluding those of the functional category "lipid metabolism" to avoid bias toward the fatty acid model (B). Genes that belong to the DosR regulon are in parentheses. (Bottom) The percentage of shared genes (A) and the percentage of genes related to reductive stress (B) are compared. The *P* values for comparisons of two percentages, as well as all three percentages, are shown. Download

###### 

Figure S4, JPG file, 0.4 MB

###### 

Validation of lipid signature genes by qRT-PCR. Genes belonging to the lipid signature ([Table 2](#tab2){ref-type="table"}) were selected for validation by qRT-PCR with RNA isolated in the stationary phase of growth under both dextrose (blue bars) and fatty acid (red bars) conditions. Data were normalized to the number of copies of the *rrs* gene (16S rRNA). Results are expressed as log~2~ of the number of copies per microgram of RNA. In some cases, the expression of the genes was below the minimum level of detection of the technique (e.g., Rv1184, Rv1733, Rv2794, Rv3416, and Rv3614). Download

###### 

Figure S5, JPG file, 0.2 MB

###### 

Excel file showing statistical analysis with Fisher's exact test (A and B). (A) DE RPKM, values for dextrose in exponential phase; FE RPKM, values for fatty acids in exponential phase. (B) DS RPKM, values for dextrose in stationary phase; FS RPKM, values for fatty acids in stationary phase. FDRs were determined by Fisher's exact test. Statistically significant differential expression between two conditions was determined by looking at genes with FDRs of \<0.05. From the top to the bottom, genes are ordered from the highest to the lowest FDRs. Top, genes with significantly higher expression in FE than in DE (A) or in FS than in DS (B); middle, genes with significantly lower expression in FE than in DE (A) or in FS than in DS (B); bottom genes with no significant differential expression among the conditions compared. (C, D) DEGseq package. (C) DE (reads), read count mapping to sense strand of gene (exponential phase in dextrose); FE (reads), read count mapping to sense strand of gene (exponential phase in fatty acids); (D) DS (reads), read count mapping to sense strand of gene (stationary phase in dextrose); FS (reads), read count mapping to sense strand of gene (stationary phase in fatty acids). Top, true significant; bottom, false significant. (E, F) Genes significantly overexpressed in the presence of LC-FA. Shown are the genes significantly overexpressed in the presence of fatty acids during exponential phase (E) and during stationary phase (F). From the top to the bottom, genes are ordered according to their tag numbers.

###### 

Table S1, PDF file, 1.7 MB.

###### 

Excel file showing RPKM data of noncoding RNAs. RPKM values of tRNAs (A) and other intergenic regions (B) and a comparison of the 21 intergenic regions with higher RPKM values (C) are shown.

###### 

Table S2, PDF file, 0.2 MB.

###### 

Functional categories with significantly increased or decreased expression in the fatty acid model. Genes were organized by functional categories (FC) according to TubercuList (<http://tuberculist.epfl.ch/>). % FC is the percentage of genes in each functional category related to the total number of genes. Total FC is the number of genes in a functional category with significantly increased or decreased expression in each phase of growth. % Total is the percentage of genes in a functional category with respect to the total number of genes with significantly increased or decreased expression in each phase of growth. % Total/% FC is the ratio of the percentages of genes with increased or decreased expression in each functional category and phase of growth. Overrepresented ratios are in bold, and underrepresented ratios are in italics.

###### 

Table S3, PDF file, 0.1 MB.

###### 

Genes related to reductive stress during growth of *M. tuberculosis* in fatty acids. (A) Number of genes related to reductive stress with significant expression during growth in different carbon sources. Genes with significantly increased or decreased expression during growth in fatty acids (FE, FS) (see [Table S3E and F](#tabS3){ref-type="supplementary-material"} in the supplemental material) were checked against 371 genes related to reductive stress (<http://www.tuberculist.epfl.ch>). The list of genes related to reductive stress includes those in the functional category of "lipid metabolism," as well as genes participating in heme group synthesis and stabilization. Growth phase: FE, Dubos medium with LC-FA in exponential phase; FS, Dubos medium with LC-FA in stationary phase. (B) Genes related to the heme prosthetic group with significantly increase expression during growth in LC-FAs. Gene tags with asterisks indicate those genes that are members of the DosR regulon.

###### 

Table S4, PDF file, 0.1 MB.

###### 

Primers used for qRT-PCR. The information provided on the primers used for qRT-PCR includes the target gene tag, the sequence, the annealing temperature, and the size of the amplified product.

###### 

Table S5, PDF file, 0.1 MB.
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